These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38684221)

  • 1. Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial.
    Choi D; Froess JD; Lawler PR; Neal MD; Zarychanski R; Rosenson RS;
    Thromb Haemost; 2024 Apr; ():. PubMed ID: 38684221
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.
    Walborn AT; Heath A; Neal MD; Zarychanski R; Kornblith LZ; Hunt BJ; Castellucci LA; Hochman JS; Lawler PR; Paul JD
    Res Pract Thromb Haemost; 2023 Oct; 7(7):102203. PubMed ID: 37854455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation as a therapeutic strategy for hospitalised patients with COVID-19.
    Cullivan S; Sholzberg M; Áinle FN; Kevane B
    Thromb Update; 2022 Mar; 6():100097. PubMed ID: 38620689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    ; ; ; Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR; Turgeon AF; Escobedo J; Huang DT; Bradbury CA; Houston BL; Kornblith LZ; Kumar A; Kahn SR; Cushman M; McQuilten Z; Slutsky AS; Kim KS; Gordon AC; Kirwan BA; Brooks MM; Higgins AM; Lewis RJ; Lorenzi E; Berry SM; Berry LR; Aday AW; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Costantini TW; de Brouwer S; Derde LPG; Detry MA; Duggal A; Džavík V; Effron MB; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Galanaud JP; Galen BT; Gandotra S; García-Madrona S; Girard TD; Godoy LC; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Hamburg NM; Haniffa R; Hanna G; Hanna N; Hegde SM; Hendrickson CM; Hite RD; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Hudock K; Hunt BJ; Husain M; Hyzy RC; Iyer VN; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski AL; King AJ; Knudson MM; Kornblith AE; Krishnan V; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Lima FG; Linstrum K; Litton E; Lopez-Sendon J; Lopez-Sendon Moreno JL; Lother SA; Malhotra S; Marcos M; Saud Marinez A; Marshall JC; Marten N; Matthay MA; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Moore SC; Morillo Guerrero R; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nunez-Garcia B; Pandey A; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pérez González YS; Pompilio M; Prekker ME; Quigley JG; Rost NS; Rowan K; Santos FO; Santos M; Olombrada Santos M; Satterwhite L; Saunders CT; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Shankar-Hari M; Sheehan JP; Singhal AB; Solvason D; Stanworth SJ; Tritschler T; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Wells BJ; Widmer RJ; Wilson JG; Yuriditsky E; Zampieri FG; Angus DC; McArthur CJ; Webb SA; Farkouh ME; Hochman JS; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):790-802. PubMed ID: 34351721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting outcomes of the acute phase of COVID-19. High sensitive prognostic model, based on the results of the international registry "analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients" (ACTIV).
    Arutyunov GP; Tarlovskaya EI; Polyakov DS; Batluk TI; Arutyunov AG
    Heliyon; 2024 Apr; 10(7):e28892. PubMed ID: 38596083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.
    Greenstein YY; Hubel K; Froess J; Wisniewski SR; Venugopal V; Lai YH; Berger JS; Chang SY; Colovos C; Shah F; Kornblith LZ; Lawler PR; Gaddh M; Guerrero RM; Nkemdirim W; Lopes RD; Reynolds HR; Amigo JS; Wahid L; Zahra A; Goligher EC; Zarychanski R; Leifer E; Huang DT; Neal MD; Hochman JS; Cushman M; Gong MN
    Chest; 2024 Apr; 165(4):785-799. PubMed ID: 37979717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of Thromboembolic Events and Mortality Among Hospitalized Coronavirus 2019 Patients: Large Observational Cohort Study of Electronic Health Records.
    Spyropoulos AC; Crawford JM; Chen YC; Ashton V; Campbell AK; Milentijevic D; Peacock WF
    TH Open; 2022 Oct; 6(4):e408-e420. PubMed ID: 36452205
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.
    Smilowitz NR; Hade EM; Kornblith LZ; Castellucci LA; Cushman M; Farkouh M; Gong MN; Heath A; Hunt BJ; Kim KS; Kindzelski A; Lawler P; Leaf DE; Goligher E; Leifer ES; McVerry BJ; Reynolds HR; Zarychanski R; Hochman JS; Neal MD; Berger JS
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102167. PubMed ID: 37727846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.
    Greenberg B; Neaton JD; Anker SD; Byra WM; Cleland JGF; Deng H; Fu M; La Police DA; Lam CSP; Mehra MR; Nessel CC; Spiro TE; van Veldhuisen DJ; Vanden Boom CM; Zannad F
    JAMA Cardiol; 2019 Jun; 4(6):515-523. PubMed ID: 31017637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-, Race- and Ethnicity-Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID-19.
    Ilyas S; Henkin S; Martinez-Camblor P; Suckow BD; Beach JM; Stone DH; Goodney PP; Ebinger JE; Creager MA; Columbo JA
    J Am Heart Assoc; 2021 Dec; 10(23):e022829. PubMed ID: 34845920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.
    Worth H; Helmlinger K; Raj R; Heidel E; Lands R
    Clin Appl Thromb Hemost; 2021; 27():10760296211053315. PubMed ID: 34786969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial.
    Bledsoe J; Woller SC; Brooks M; Sciurba FC; Krishnan JA; Martin D; Hou P; Lin JY; Kindzelski A; Handberg E; Kirwan BA; Zaharris E; Castro L; Shapiro NL; Pepine CJ; Majercik S; Fu Z; Zhong Y; Venugopal V; Lai YH; Ridker PM; Connors JM
    BMC Infect Dis; 2023 May; 23(1):325. PubMed ID: 37189091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of blood viscosity and device-free days among hospitalized patients with COVID-19.
    Waksman O; Choi D; Mar P; Chen Q; Cho DJ; Kim H; Smith RL; Goonewardena SN; Rosenson RS
    J Intensive Care; 2023 May; 11(1):17. PubMed ID: 37131249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of thromboembolic events in hospitalized COVID-19 patients.
    Fontelo P; Bastola MM; Zheng Z; Baik SH
    Thromb J; 2021 Jun; 19(1):47. PubMed ID: 34187490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Thromboembolic Events in Hospitalized COVID-19 Patients.
    Fontelo P; Bastola MM; Zheng Z; Baik SH
    Res Sq; 2021 Apr; ():. PubMed ID: 33851147
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
    Houston BL; Lawler PR; Goligher EC; Farkouh ME; Bradbury C; Carrier M; Dzavik V; Fergusson DA; Fowler RA; Galanaud JP; Gross PL; McDonald EG; Husain M; Kahn SR; Kumar A; Marshall J; Murthy S; Slutsky AS; Turgeon AF; Berry SM; Rosenson RS; Escobedo J; Nicolau JC; Bond L; Kirwan BA; de Brouwer S; Zarychanski R
    Clin Trials; 2020 Oct; 17(5):491-500. PubMed ID: 32815416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
    Connors JM; Brooks MM; Sciurba FC; Krishnan JA; Bledsoe JR; Kindzelski A; Baucom AL; Kirwan BA; Eng H; Martin D; Zaharris E; Everett B; Castro L; Shapiro NL; Lin JY; Hou PC; Pepine CJ; Handberg E; Haight DO; Wilson JW; Majercik S; Fu Z; Zhong Y; Venugopal V; Beach S; Wisniewski S; Ridker PM;
    JAMA; 2021 Nov; 326(17):1703-1712. PubMed ID: 34633405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors.
    Eswaran H; Jarmul JA; Shaheen AW; Meaux D; Long T; Saccoccio D; Moll S
    Res Pract Thromb Haemost; 2021 Feb; 5(2):292-295. PubMed ID: 33733027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic Events and Role of Point of Care Ultrasound in Hospitalized Covid-19 Patients Needing Intensive Care Unit Admission.
    Kapoor S; Chand S; Dieiev V; Fazzari M; Tanner T; Lewandowski DC; Nalla A; Abdulfattah O; Aboodi MS; Shiloh AL; Gong MN
    J Intensive Care Med; 2021 Dec; 36(12):1483-1490. PubMed ID: 33021131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.